1. Chen YP, Chan ATC, Le QT, et al. (2019) Nasopharyngeal carcinoma. Lancet, 394(10192): 64-80. [ DOI:10.1016/S0140-6736(19)30956-0] 2. Zhang LF, Li YH, Xie SH, et al. (2015) Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, China. Chin J Cancer, 34(8): 350-357. [ DOI:10.1186/s40880-015-0018-6] 3. Lee AW, Ng WT, Chan LL, et al. (2014) Evolution of radiotherapy for nasopharyngeal carcinoma. Lancet Oncol, 15(6): e268-e278. [ DOI:10.1016/S1470-2045(13)70591-6] 4. Bressan V, Bagnasco A, Aleo G, et al. (2018) Nutritional interventions in head and neck cancer patients undergoing radiotherapy: A systematic review. Support Care Cancer, 26(10): 3267-3277. 5. Talwar B, Donnelly R, Skelly R, et al. (2016) Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol, 130(S2): S32-S40. [ DOI:10.1017/S0022215116000402] 6. Couch ME, Dittus K, Toth MJ, et al. (2015) Cancer cachexia and nutritional interventions. Nutr Clin Pract, 30(5): 608-617. 7. Argilés JM, Busquets S, Stemmler B, López-Soriano FJ (2014) Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer, 14(11):754-762. [ DOI:10.1038/nrc3829] 8. Mula-Hussain L, Alabedi H, Al-Kindy B, et al. (2020) Nephrotoxicity of cisplatin in head and neck cancer patients. Front Oncol, 10: 567. 9. Liu P, Mei W, Zhou M, et al. (2023) Application of mind map in health education for children with vasovagal syncope. Front Cardiovasc Med, 10: 1051677. [ DOI:10.3389/fcvm.2023.1051677] 10. Li X, Zhao J, Fu S (2022) SBAR standard and mind map combined communication mode used in emergency department to reduce handover defects. J Healthc Eng, 2022: 8475322. [ DOI:10.1155/2022/8475322] 11. McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treat Rev, 39(5): 534-540. [ DOI:10.1016/j.ctrv.2012.08.003] 12. Findlay M, Bauer J, Brown T, et al. (2014) Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer. Head Neck, 36(4): 527-535. 13. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, et al. (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol, 26(22): 3770-3776. [ DOI:10.1200/JCO.2007.14.6647] 14. Nutting CM, Morden JP, Harrington KJ, et al. (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicenter randomized controlled trial. Lancet Oncol, 12(2): 127-136. [ DOI:10.1016/S1470-2045(10)70290-4] 15. Locher JL, Bonner JA, Carroll WR, et al. (2011) Prophylactic percutaneous endoscopic gastrostomy tube placement in head and neck cancer patients: A systematic review. Head Neck, 33(8):1129-1138. 16. van den Berg MG, Rutten H, Rasmussen-Conrad EL, et al. (2014) Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: A cross-sectional study. Head Neck, 36(1): 60-65. [ DOI:10.1002/hed.23265] 17. Capuano G, Gentile PC, Bianciardi F, et al. (2012) Nutritional management of head and neck cancer patients during and after treatment: A prospective observational study. Nutr Cancer, 64(6): 814-821. 18. Paccagnella A, Morello M, Da Mosto MC, et al. (2010) Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer, 18(7): 837-845. [ DOI:10.1007/s00520-009-0717-0] 19. Skinner R, Pearson AD, English MW, et al. (1998) Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer, 77(10): 1677-1682. [ DOI:10.1038/bjc.1998.276] 20. Launay-Vacher V, Oudard S, Janus N, et al. (2007) Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: The renal insufficiency and anticancer medications (IRMA) study. Cancer, 110(6): 1376-1384. [ DOI:10.1002/cncr.22904] 21. Fearon K, Strasser F, Anker SD, et al. (2011) Definition and classification of cancer cachexia: An international consensus. Lancet Oncol, 12(5): 489-495. [ DOI:10.1016/S1470-2045(10)70218-7] 22. Gabay C and Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340(6): 448-454. [ DOI:10.1056/NEJM199902113400607] 23. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101(15): 1767-1772. [ DOI:10.1161/01.CIR.101.15.1767] 24. Mehta NN, deGoma E, Shapiro MD (2024) IL-6 and Cardiovascular Risk: A Narrative Review. Curr Atheroscler Rep, 27(1): 12. [ DOI:10.1007/s11883-024-01259-7] 25. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol, 12(2): 127-36. [ DOI:10.1016/S1470-2045(10)70290-4] 26. Liu P, Mei W, Zhou M, Zhao T, Wang Y, Zou R, et al. (2023) Application of mind map can promote the health education effect of children with vasovagal syncope. Front Cardiovasc Med, 10: 1051677. [ DOI:10.3389/fcvm.2023.1051677] 27. Locher JL, Bonner JA, Carroll WR, Caudell JJ, Keith JN, Kilgore ML, et al. (2011) Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr, 35(3):365-74. [ DOI:10.1177/0148607110377097]
|